Disparities in the surgical management of early stage non-small cell lung cancer: How far have we come?

Omar Toubat, Albert J. Farias, Scott M. Atay, P. Michael McFadden, Anthony W. Kim, Elizabeth David

Research output: Contribution to journalReview article

Abstract

It is currently estimated that nearly one-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) have stage I–II disease on clinical evaluation. Curative-intent surgical resection has been a cornerstone of the therapeutic management of such patients, offering the best clinical and oncologic outcomes in the long-term. In 1999, Peter Bach and colleagues brought attention to racial disparities in the receipt of curative-intent surgery in the NSCLC population. In the time since this seminal study, there is accumulating evidence to suggest that disparities in the receipt of definitive surgery continue to persist for patients with early stage NSCLC. In this review, we sought to provide an up-to-date assessment of 20 years of surgical disparities literature in the NSCLC population. We summarized common and unrecognized disparities in the receipt of surgical resection for early stage NSCLC and demonstrated that demographic and socioeconomic factors such as race/ethnicity, special patient groups, income and insurance continue to impact the receipt of definitive resection. Additionally, we found that discrepancies in patient and provider perceptions of and attitudes toward surgery, access to invasive staging, distance to treatment centers and negative stigmas about lung cancer that patients experience may act to perpetuate disparities in surgical treatment of early stage lung cancer.

Original languageEnglish (US)
Pages (from-to)S596-S611
JournalJournal of Thoracic Disease
Volume11
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Neoplasms
Insurance
Population
Therapeutics
Demography

Keywords

  • Early stage non-small cell lung cancer (NSCLC)
  • Lung cancer
  • Surgical disparities
  • Treatment inequity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Disparities in the surgical management of early stage non-small cell lung cancer : How far have we come? / Toubat, Omar; Farias, Albert J.; Atay, Scott M.; McFadden, P. Michael; Kim, Anthony W.; David, Elizabeth.

In: Journal of Thoracic Disease, Vol. 11, 01.01.2019, p. S596-S611.

Research output: Contribution to journalReview article

Toubat, Omar ; Farias, Albert J. ; Atay, Scott M. ; McFadden, P. Michael ; Kim, Anthony W. ; David, Elizabeth. / Disparities in the surgical management of early stage non-small cell lung cancer : How far have we come?. In: Journal of Thoracic Disease. 2019 ; Vol. 11. pp. S596-S611.
@article{99c93e5f29be4a839fe4b51312c12f84,
title = "Disparities in the surgical management of early stage non-small cell lung cancer: How far have we come?",
abstract = "It is currently estimated that nearly one-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) have stage I–II disease on clinical evaluation. Curative-intent surgical resection has been a cornerstone of the therapeutic management of such patients, offering the best clinical and oncologic outcomes in the long-term. In 1999, Peter Bach and colleagues brought attention to racial disparities in the receipt of curative-intent surgery in the NSCLC population. In the time since this seminal study, there is accumulating evidence to suggest that disparities in the receipt of definitive surgery continue to persist for patients with early stage NSCLC. In this review, we sought to provide an up-to-date assessment of 20 years of surgical disparities literature in the NSCLC population. We summarized common and unrecognized disparities in the receipt of surgical resection for early stage NSCLC and demonstrated that demographic and socioeconomic factors such as race/ethnicity, special patient groups, income and insurance continue to impact the receipt of definitive resection. Additionally, we found that discrepancies in patient and provider perceptions of and attitudes toward surgery, access to invasive staging, distance to treatment centers and negative stigmas about lung cancer that patients experience may act to perpetuate disparities in surgical treatment of early stage lung cancer.",
keywords = "Early stage non-small cell lung cancer (NSCLC), Lung cancer, Surgical disparities, Treatment inequity",
author = "Omar Toubat and Farias, {Albert J.} and Atay, {Scott M.} and McFadden, {P. Michael} and Kim, {Anthony W.} and Elizabeth David",
year = "2019",
month = "1",
day = "1",
doi = "10.21037/jtd.2019.01.63",
language = "English (US)",
volume = "11",
pages = "S596--S611",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",

}

TY - JOUR

T1 - Disparities in the surgical management of early stage non-small cell lung cancer

T2 - How far have we come?

AU - Toubat, Omar

AU - Farias, Albert J.

AU - Atay, Scott M.

AU - McFadden, P. Michael

AU - Kim, Anthony W.

AU - David, Elizabeth

PY - 2019/1/1

Y1 - 2019/1/1

N2 - It is currently estimated that nearly one-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) have stage I–II disease on clinical evaluation. Curative-intent surgical resection has been a cornerstone of the therapeutic management of such patients, offering the best clinical and oncologic outcomes in the long-term. In 1999, Peter Bach and colleagues brought attention to racial disparities in the receipt of curative-intent surgery in the NSCLC population. In the time since this seminal study, there is accumulating evidence to suggest that disparities in the receipt of definitive surgery continue to persist for patients with early stage NSCLC. In this review, we sought to provide an up-to-date assessment of 20 years of surgical disparities literature in the NSCLC population. We summarized common and unrecognized disparities in the receipt of surgical resection for early stage NSCLC and demonstrated that demographic and socioeconomic factors such as race/ethnicity, special patient groups, income and insurance continue to impact the receipt of definitive resection. Additionally, we found that discrepancies in patient and provider perceptions of and attitudes toward surgery, access to invasive staging, distance to treatment centers and negative stigmas about lung cancer that patients experience may act to perpetuate disparities in surgical treatment of early stage lung cancer.

AB - It is currently estimated that nearly one-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) have stage I–II disease on clinical evaluation. Curative-intent surgical resection has been a cornerstone of the therapeutic management of such patients, offering the best clinical and oncologic outcomes in the long-term. In 1999, Peter Bach and colleagues brought attention to racial disparities in the receipt of curative-intent surgery in the NSCLC population. In the time since this seminal study, there is accumulating evidence to suggest that disparities in the receipt of definitive surgery continue to persist for patients with early stage NSCLC. In this review, we sought to provide an up-to-date assessment of 20 years of surgical disparities literature in the NSCLC population. We summarized common and unrecognized disparities in the receipt of surgical resection for early stage NSCLC and demonstrated that demographic and socioeconomic factors such as race/ethnicity, special patient groups, income and insurance continue to impact the receipt of definitive resection. Additionally, we found that discrepancies in patient and provider perceptions of and attitudes toward surgery, access to invasive staging, distance to treatment centers and negative stigmas about lung cancer that patients experience may act to perpetuate disparities in surgical treatment of early stage lung cancer.

KW - Early stage non-small cell lung cancer (NSCLC)

KW - Lung cancer

KW - Surgical disparities

KW - Treatment inequity

UR - http://www.scopus.com/inward/record.url?scp=85065182810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065182810&partnerID=8YFLogxK

U2 - 10.21037/jtd.2019.01.63

DO - 10.21037/jtd.2019.01.63

M3 - Review article

AN - SCOPUS:85065182810

VL - 11

SP - S596-S611

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

ER -